AFT sees upside from Australian plans to restrict codeine sales

AFT sees upside from Australian plans to restrict codeine sales
Paul McBeth
By Rebecca Howard Dec. 20 (BusinessDesk) – New Zealand’s AFT Pharmaceuticals expects to benefit from news that all medicines containing codeine will be prescription-only in Australia from Feb. 1, 2018. Australia’s medicine’s watchdog, the Therapeutic Goods Administration or TGA, today confirmed products containing codeine will not be able to be sold over the counter in pharmacies. Auckland-based AFT managing director Hartley Atkinson said his company will “undoubtedly” experience a sales increase across the Tasman as a result of the de...